School of Medicine

If not for his interest in nutrition, Samuel Klein, M.D., might never have gone to medical school. Originally, he was planning to become a marine biologist. There’s still some evidence of his first career choice in the corner of his office, where a tank full of exotic fish gurgles. But science and Klein both benefited […]

Photo by Bob BostonRecent graduates work in the recently completed space that houses the University’s new genetic epidemiology master of science degree program.

MorganOccupational Therapy Instructor Kerri Morgan and Shae Communications CEO Kevin Brown set a precedent Sept. 4 when the two compete in the Lake St. Louis Triathlon. The athletes will be the first-ever to compete in the event’s newly created wheelchair division. Columnist Kathleen Nelson tells the full story in the following St. Louis Post-Dispatch article.

Approximately 1 million stroke victims suffer from a condition called aphasia, which can affect reading, writing, speaking or understanding speech. Generally, speech therapists rely on their own experience and intuition to determine treatment for these patients, but a multidisciplinary research team from the School of Medicine has developed a speech rehabilitation program using the same evidence-based approach used by physicians and surgeons.

A Christian, a clown and a scientist — It may sound like the beginning of a bad joke, but it’s actually an accurate description of the life of WUSM professor Dana Abendschein. The following St. Louis Post-Dispatch article by Harry Jackson Jr. tells the story of how an overachieving researcher found fulfillment in a clown suit.

Washington University School of Medicine in St. Louis is a long-time leader in medical research and clinical practice. The school employs a number of experts in many areas of expertise, including health care policy issues. Under the direction of former dean William Peck, the university has established the Center for Health Policy to: Identify key […]

He completed both his residency in internal medicine and a fellowship in gastroenterology at the School of Medicine.

The cancer physician-scientist from Massachusetts General Hospital and Harvard University will join the University Oct. 1.

A five-year, $2.5 million grant may help employers determine which employees are more likely to get the condition.

School of Medicine scientists suspect a drug already approved for seizure disorders and chronic nerve pain can also help.